» Articles » PMID: 30003009

How Low Can We Go? The Implications of Low Bacterial Load in Respiratory Microbiota Studies

Overview
Publisher Biomed Central
Date 2018 Jul 14
PMID 30003009
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Culture-independent sequencing methods are increasingly used to investigate the microbiota associated with human mucosal surfaces, including sites that have low bacterial load in healthy individuals (e.g. the lungs). Standard microbiota methods developed for analysis of high bacterial load specimens (e.g. stool) may require modification when bacterial load is low, as background contamination derived from sterile laboratory reagents and kits can dominate sequence data when few bacteria are present.

Main Body: Bacterial load in respiratory specimens may vary depending on the specimen type, specimen volume, the anatomic site sampled and clinical parameters. This review discusses methodological issues inherent to analysis of low bacterial load specimens and recommends strategies for successful respiratory microbiota studies. The range of methods currently used to process DNA from low bacterial load specimens, and the strategies used to identify and exclude background contamination are also discussed.

Conclusion: Microbiota studies that include low bacterial load specimens require additional tests to ensure that background contamination does not bias the results or interpretation. Several methods are currently used to analyse the microbiota in low bacterial load respiratory specimens; however, there is scant literature comparing the effectiveness and biases of different methods. Further research is needed to define optimal methods for analysing the microbiota in low bacterial load specimens.

Citing Articles

The human lung microbiome-A hidden link between microbes and human health and diseases.

Yi X, Gao J, Wang Z Imeta. 2024; 1(3):e33.

PMID: 38868714 PMC: 10989958. DOI: 10.1002/imt2.33.


Positioning the preventive potential of microbiome treatments for cystic fibrosis in the context of current therapies.

Cauwenberghs E, De Boeck I, Spacova I, Van Tente I, Bastiaenssen J, Lammertyn E Cell Rep Med. 2024; 5(1):101371.

PMID: 38232705 PMC: 10829789. DOI: 10.1016/j.xcrm.2023.101371.


Recovery of microbial DNA by agar-containing solution from extremely low-biomass specimens including skin.

Kurokawa R, Masuoka H, Takayasu L, Kiguchi Y, Ogata Y, Miura-Kawatsu R Sci Rep. 2023; 13(1):19666.

PMID: 37952000 PMC: 10640576. DOI: 10.1038/s41598-023-46890-7.


Characterization of cerebrospinal fluid (CSF) microbiota at the time of initial surgical intervention for children with hydrocephalus.

Pandey S, Whitlock K, Test M, Hodor P, Pope C, Limbrick Jr D PLoS One. 2023; 18(6):e0280682.

PMID: 37342995 PMC: 10284395. DOI: 10.1371/journal.pone.0280682.


Detection of bile acids in bronchoalveolar lavage fluid defines the inflammatory and microbial landscape of the lower airways in infants with cystic fibrosis.

Caparros-Martin J, Saladie M, Agudelo-Romero S, Reen F, Ware R, Sly P Microbiome. 2023; 11(1):132.

PMID: 37312128 PMC: 10262387. DOI: 10.1186/s40168-023-01543-9.


References
1.
Schnell I, Bohmann K, Gilbert M . Tag jumps illuminated--reducing sequence-to-sample misidentifications in metabarcoding studies. Mol Ecol Resour. 2015; 15(6):1289-303. DOI: 10.1111/1755-0998.12402. View

2.
Bogaert D, Keijser B, Huse S, Rossen J, Veenhoven R, van Gils E . Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis. PLoS One. 2011; 6(2):e17035. PMC: 3046172. DOI: 10.1371/journal.pone.0017035. View

3.
Willner D, Daly J, Whiley D, Grimwood K, Wainwright C, Hugenholtz P . Comparison of DNA extraction methods for microbial community profiling with an application to pediatric bronchoalveolar lavage samples. PLoS One. 2012; 7(4):e34605. PMC: 3326054. DOI: 10.1371/journal.pone.0034605. View

4.
Jervis-Bardy J, Leong L, Marri S, Smith R, Choo J, Smith-Vaughan H . Deriving accurate microbiota profiles from human samples with low bacterial content through post-sequencing processing of Illumina MiSeq data. Microbiome. 2015; 3:19. PMC: 4428251. DOI: 10.1186/s40168-015-0083-8. View

5.
Lewis D, Brown R, Williams J, White P, Jacobson S, Marchesi J . The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infect Microbiol. 2013; 3:41. PMC: 3744036. DOI: 10.3389/fcimb.2013.00041. View